贝达药业(300558.SZ)：盐酸埃克替尼术后辅助治疗适应症和盐酸恩沙替尼纳入《国家医保目录》

格隆汇12月3日丨贝达药业(300558.SZ)公布，2021年12月3日，根据国家医保局、人力资源社会保障部印发的《关于印发〈国家基本医疗保险、工伤保险和生育保险药品目录(2021年)〉的通知》【医保发〔2021〕50号】，公司产品盐酸埃克替尼片(凯美纳®)术后辅助治疗适应症和盐酸恩沙替尼胶囊(贝美纳®)双双谈判成功，新纳入《国家基本医疗保险、工伤保险和生育保险药品目录(2021年)》。

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.